Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0X0CH
|
||||
| Former ID |
DCL000811
|
||||
| Drug Name |
Ganaxolone
|
||||
| Synonyms |
Ganaxolone [USAN]; CCD 1042; CCD-1042; Ganaxolone (USAN/INN); (3alpha,5alpha)-3-Hydroxy-3-methylpregnan-20-one; 1-[(3R,5S,10S,13S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone; 1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone; 3alpha-Hydroxy-3-methyl-5alpha-pregnan-20-one; 3alpha-Hydroxy-3beta-methyl-5alpha-pregnan-20-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Epilepsy [ICD10:G40] | Phase 2 | [536934] | ||
| Company |
Marinus
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C22H36O2
|
||||
| Canonical SMILES |
CC(=O)C1CCC2C1(CCC3C2CCC4C3(CCC(C4)(C)O)C)C
|
||||
| InChI |
1S/C22H36O2/c1-14(23)17-7-8-18-16-6-5-15-13-20(2,24)11-12-21(15,3)19(16)9-10-22(17,18)4/h15-19,24H,5-13H2,1-4H3/t15-,16+,17-,18+,19+,20-,21+,22-/m1/s1
|
||||
| InChIKey |
PGTVWKLGGCQMBR-HNABIGDDSA-N
|
||||
| CAS Number |
CAS 38398-32-2
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | GABA A receptor delta subunit | Target Info | Modulator | ||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.